ROCHESTER, Mich. , March 04, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading digital health messaging platform for the pharmaceutical industry, has been invited to present at the 31st Annual ROTH Conference being held at The Ritz Carlton, Laguna Niguel in Orange County,
ROCHESTER, Mich. , Feb. 26, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, reported results for the fourth quarter and year ended December 31, 2018 . Quarterly comparisons are to the same year-ago quarter.
ROCHESTER, Mich. , Feb. 13, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, will hold a conference call on Tuesday, February 26, 2019 at 4:30 p.m. Eastern time to discuss results for the fourth quarter and
ROCHESTER, Mich. , Feb. 11, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, announced today its initial findings from a physician survey focused on prescription drug costs.
Panel encourages physicians to provide input on industry efforts to address and improve pharma-to-provider communication ROCHESTER, Mich. , Feb. 07, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has formed
Partnership to open lines of communication between pharma, providers and patients, supporting financial, clinical and drug education ROCHESTER, Mich. , Jan. 29, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry,
ROCHESTER, Mich. , Dec. 18, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, today announced the pricing of the previously announced underwritten public offering by WPP Luxembourg Gamma Three S.à r.l., a
ROCHESTER, Mich. , Dec. 17, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, today announced a proposed underwritten public offering by WPP Luxembourg Gamma Three S.à r.l., a shareholder of OptimizeRx ,
ROCHESTER, Mich. , Nov. 30, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, joined the MSCI USA Microcap Index at the conclusion of the MSCI indexes semi-annual reconstitution, effective after the U.S.
